Research Paper Volume 12, Issue 22 pp 23306—23325

Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer

Figure 6. Prognostic value of 8-IRlncRNA classifier for assessing recurrence-free survival (RFS). (A, B) Kaplan-Meier analysis for RFS of BLCA patients based on the risk stratification in the training set (A) and validating set (B). (C, D) Receiver operating characteristic (ROC) analysis for RFS prediction including 1-, 3-, 5-year of BLCA patients in the training set (C) and validating set (D).